PRE-MARKET INDIAN STOCKS NEWS: Earnings from Container Corp. of India, ITC, National Aluminium Co, and Petronet

Container Corporation of India (CCRI IN) - Co. Q2 (INR) net fell 6.8% Y/Y to 3.53bln, rev. rose 1% Y/Y to 23.79bln. (Economic Times)

IDBI Bank (IDBI IN) - Co. employees and officers began a two-day nationwide strike on November 2-3 opposing the proposed sale of a controlling stake in the lender to Canada's Fairfax Financial Holdings. (Economic Times)

ITC (ITC IN) - Co. Q2 (INR) net fell 18.5% Y/Y to 42.29bln, rev. rose 5% Y/Y to 204.54bln, with weaker cigarette earnings weighing on profitability despite growth in FMCG, agriculture and paper businesses. (Economic Times)

KEC International (KECI IN) - Co. Q2 (INR) net fell 81.5% Y/Y to 297mln, rev. fell 10.2% Y/Y to 54.677bln. (Moneycontrol)

Lupin (LPC IN) - Co. received US FDA approval for its abbreviated new drug application for Amifampridine Tablets 10mg, a generic equivalent of Catalyst Pharmaceuticals' Firdapse. (Moneycontrol)

Marico (MRCO IN) - Co. Q2 (INR) net rose 31% Y/Y to 5.5bln. (Economic Times)

National Aluminium Company (NACL IN) - Co. Q2 (INR) net rose 28.3% Y/Y to 18.35bln, rev. rose 26.3% Y/Y to 54.19bln, approved FY27 interim dividend of INR 4.50/shr with November 6 as the record date. (Moneycontrol/Economic Times)

Petronet LNG (PLNG IN) - Co. Q2 (INR) net rose 9.1% Q/Q to 12.3bln, rev. rose 29.6% Q/Q to 72bln. (Economic Times)

PTC India (PTC IN) - Co. Q2 (INR) net fell 24.8% Y/Y to 1.44bln, EBITDA fell 48.1% Y/Y to 1.43bln, rev. rose 6.5% Y/Y to 58.12bln. (Economic Times)

Sun Pharmaceutical Industries (SUNP IN) - Co. clarified that reports of an order to halt production of an eye-care drug at one of its plants related to developments in August 2026, with no new developments on October 30. (Economic Times)

A pre-market roundup of this kind tends to trade as a stock-specific session rather than an index event; in past Indian earnings seasons, single-name beats and misses have generated outsized relative moves while the benchmark absorbed the aggregate quietly. The recurring pattern in this set is margin compression against resilient topline: several prints show revenue growth alongside falling net income, a combination that has historically pointed to input-cost or mix pressure rather than demand weakness, and which has tended to draw the sharpest reaction where the miss is concentrated in a core franchise segment, as with the cigarette-linked drag at ITC. Metals and energy names reporting profit growth alongside revenue gains fit the pattern of upstream beneficiaries in periods of firm commodity realisations, and dividend declarations in that cohort have typically been read as cash-flow confirmation rather than fresh information. The IDBI strike item belongs to the privatisation category: labour action around state-bank stake sales has on previous occasions disrupted process timelines more than it has repriced the equity, with the tell being whether the government signals any delay. Regulatory clarifications of the Sun Pharma type have generally faded quickly when the company asserts no new development, though FDA-adjacent headlines in Indian generics names have a record of lingering if follow-up correspondence surfaces.